(Q28237971)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24722429%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Robert C Baxter

series ordinal

1

0 references

language of work or name

English

0 references

publication date

May 2014

0 references

published in

Nature Reviews Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24722429%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24722429%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24722429%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

329-341

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24722429%20AND%20SRC:MED&resulttype=core&format=json

Molecular basis of signaling specificity of insulin and IGF receptors: neglected corners and recent advances

13 June 2020

cites work

1 reference

The insulin-like growth factor-binding protein (IGFBP) superfamily

20 April 2017

1 reference

The CCN family of proteins: structure-function relationships

20 April 2017

1 reference

Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions

20 April 2017

1 reference

Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling

20 April 2017

1 reference

Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit

20 April 2017

1 reference

Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma

20 April 2017

1 reference

Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans

20 April 2017

1 reference

ADAM28 is overexpressed in human breast carcinomas: implications for carcinoma cell proliferation through cleavage of insulin-like growth factor binding protein-3

20 April 2017

1 reference

Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma

20 April 2017

1 reference

Cellular actions of the insulin-like growth factor binding proteins

20 April 2017

1 reference

Unraveling insulin-like growth factor binding protein-3 actions in human disease

20 April 2017

1 reference

Cellular growth inhibition by IGFBP-3 and TGF-beta1 requires LRP-1

20 April 2017

1 reference

Cellular internalization of insulin-like growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization

20 April 2017

1 reference

Insulin-like growth factor-independent effects mediated by a C-terminal metal-binding domain of insulin-like growth factor binding protein-3

20 April 2017

1 reference

Analysis of the cellular uptake and nuclear delivery of insulin-like growth factor binding protein-3 in human osteosarcoma cells

20 April 2017

1 reference

Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin beta subunit

20 April 2017

1 reference

PAPA-1 Is a nuclear binding partner of IGFBP-2 and modulates its growth-promoting actions

20 April 2017

1 reference

Regulation of multiple insulin-like growth factor binding protein genes by 1alpha,25-dihydroxyvitamin D3.

20 April 2017

1 reference

Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis

20 April 2017

1 reference

Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells

20 April 2017

1 reference

Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions

20 April 2017

1 reference

Contribution of the orphan nuclear receptor Nur77 to the apoptotic action of IGFBP-3

20 April 2017

1 reference

Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer

20 April 2017

1 reference

Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence

20 April 2017

1 reference

Potentiation of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activity

20 April 2017

1 reference

IGFBP-3 binds GRP78, stimulates autophagy and promotes the survival of breast cancer cells exposed to adverse microenvironments

20 April 2017

1 reference

Induction of the growth inhibitor IGF-binding protein 3 by p53

20 April 2017

1 reference

Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells

20 April 2017

1 reference

The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents

20 April 2017

1 reference

EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment

20 April 2017

1 reference

Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma

20 April 2017

1 reference

From insulin and insulin-like activity to the insulin superfamily of growth-promoting peptides: a 20th-century odyssey

20 April 2017

1 reference

Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease.

31 March 2020

1 reference

The insulin and insulin-like growth factor receptor family in neoplasia: an update

31 March 2020

1 reference

Minireview: nuclear insulin and insulin-like growth factor-1 receptors: a novel paradigm in signal transduction

31 March 2020

1 reference

Evolution of the insulin-like growth factor binding protein (IGFBP) family

31 March 2020

1 reference

Evolution of ancient functions in the vertebrate insulin-like growth factor system uncovered by study of duplicated salmonid fish genomes

31 March 2020

1 reference

Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities

31 March 2020

1 reference

Insulin-like growth factor binding proteins: a structural perspective

31 March 2020

1 reference

IGF-binding proteins--the pieces are falling into place.

31 March 2020

1 reference

Amino- and carboxyl-terminal fragments of insulin-like growth factor (IGF) binding protein-3 cooperate to bind IGFs with high affinity and inhibit IGF receptor interactions.

31 March 2020

1 reference

Cooperativity of the N- and C-terminal domains of insulin-like growth factor (IGF) binding protein 2 in IGF binding

31 March 2020

1 reference

Circulating binding proteins for the insulinlike growth factors

31 March 2020

1 reference

Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex

31 March 2020

1 reference

Molecular interactions in the insulin-like growth factor (IGF) axis: a surface plasmon resonance (SPR) based biosensor study

31 March 2020

1 reference

Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability

31 March 2020

1 reference

Matrix metalloproteinase-9 interplays with the IGFBP2-IGFII complex to promote cell growth and motility in astrocytomas

31 March 2020

1 reference

Overexpression of pregnancy-associated plasma protein-A in ovarian cancer cells promotes tumor growth in vivo

31 March 2020

1 reference

Insulin-like growth factor-binding protein-1: a role in glucose counterregulation?

31 March 2020

1 reference

Obesity and cancer risk: the role of the insulin-IGF axis

31 March 2020

1 reference

The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition.

31 March 2020

1 reference

Biochemical characterization of individual human glycosylated pro-insulin-like growth factor (IGF)-II and big-IGF-II isoforms associated with cancer.

31 March 2020

1 reference

Impaired formation of the ternary insulin-like growth factor-binding protein complex in patients with hypoglycemia due to nonislet cell tumors

31 March 2020

1 reference

Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progression

31 March 2020

1 reference

Murine osteosarcoma primary tumour growth and metastatic progression is maintained after marked suppression of serum insulin-like growth factor I.

31 March 2020

1 reference

A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesis

31 March 2020

1 reference

Insulin-like growth factor (IGF) binding protein-3 attenuates prostate tumor growth by IGF-dependent and IGF-independent mechanisms.

31 March 2020

1 reference

Insulin-like growth factor binding protein-3 suppresses vascular endothelial growth factor expression and tumor angiogenesis in head and neck squamous cell carcinoma

31 March 2020

1 reference

IGFBP-3 is a metastasis suppression gene in prostate cancer

31 March 2020

1 reference

Elevated serum insulin-like growth factor binding protein-2 as a prognostic marker in patients with ovarian cancer

31 March 2020

1 reference

Elevated serum antibodies against insulin-like growth factor-binding protein-2 allow detecting early-stage cancers: evidences from glioma and colorectal carcinoma studies.

31 March 2020

1 reference

Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex

31 March 2020

1 reference

Involvement of insulin-like growth factor-binding protein-3 in the effects of histone deacetylase inhibitor MS-275 in hepatoma cells

31 March 2020

1 reference

Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma

31 March 2020

1 reference

Insulin-like growth factor binding protein-3 (IGFBP-3) plays a role in the anti-tumorigenic effects of 5-Aza-2'-deoxycytidine (AZA) in breast cancer cells.

31 March 2020

1 reference

Functional modulation of IGF-binding protein-3 expression in melanoma

31 March 2020

1 reference

Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors

31 March 2020

1 reference

Methylation of the insulin-like growth factor binding protein-3 gene and prognosis of epithelial ovarian cancer

31 March 2020

1 reference

In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer.

31 March 2020

1 reference

IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer.

31 March 2020

1 reference

Insulin-like growth factor binding protein-4 gene silencing in lung adenocarcinomas.

31 March 2020

1 reference

Perspectives in mammalian IGFBP-3 biology: local vs. systemic action

31 March 2020

1 reference

IGF binding proteins (IGFBPs) and regulation of breast cancer biology.

31 March 2020

1 reference

Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding.

31 March 2020

1 reference

Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins

31 March 2020

1 reference

Cumulative mutagenesis of the basic residues in the 201-218 region of insulin-like growth factor (IGF)-binding protein-5 results in progressive loss of both IGF-I binding and inhibition of IGF-I biological action

31 March 2020

1 reference

Expression of a protease-resistant insulin-like growth factor-binding protein-4 inhibits tumour growth in a murine model of breast cancer

31 March 2020

1 reference

Insulin-like growth factor-binding protein-6 and cancer.

31 March 2020

1 reference

Role of insulin-like growth factor-1 signaling pathway in cisplatin-resistant lung cancer cells

31 March 2020

1 reference

Accumulation of insulin-like growth factor binding protein-3 in conditioned medium of human fibroblasts increases with chronologic age of donor and senescence in vitro

31 March 2020

1 reference

Plasminogen activator inhibitor 1--insulin-like growth factor binding protein 3 cascade regulates stress-induced senescence

31 March 2020

1 reference

Recombinant human insulin-like growth factor-binding protein 3 inhibits tumor growth and targets the Akt pathway in lung and colon cancer models

31 March 2020

1 reference

Insulin-like growth factor-binding protein-1 (IGFBP-1) regulates human schwannoma proliferation, adhesion and survival.

31 March 2020

1 reference

An interaction between insulin-like growth factor-binding protein 2 (IGFBP2) and integrin alpha5 is essential for IGFBP2-induced cell mobility

31 March 2020

1 reference

Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor-independent urokinase-type plasminogen activator inhibition

31 March 2020

1 reference

IGF-independent effects of insulin-like growth factor binding protein-5 (Igfbp5) in vivo

31 March 2020

1 reference

Interactions of high affinity insulin-like growth factor-binding proteins with the type V transforming growth factor-beta receptor in mink lung epithelial cells

31 March 2020

1 reference

Loss of core fucosylation of low-density lipoprotein receptor-related protein-1 impairs its function, leading to the upregulation of serum levels of insulin-like growth factor-binding protein 3 in Fut8-/- mice

31 March 2020

1 reference

Nuclear transport of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in opossum kidney cells

31 March 2020

1 reference

31 March 2020

1 reference

Insulin-like growth factor-binding protein-5 enters vesicular structures but not the nucleus.

31 March 2020

1 reference

Decreased caveolin-1 levels contribute to fibrosis and deposition of extracellular IGFBP-5.

31 March 2020

1 reference

IGFBP-3 nuclear localization predicts human prostate cancer recurrence

31 March 2020

1 reference

Nuclear insulin-like growth factor binding protein-3 induces apoptosis and is targeted to ubiquitin/proteasome-dependent proteolysis.

31 March 2020

1 reference

A functional nuclear localization signal in insulin-like growth factor binding protein-6 mediates its nuclear import

31 March 2020

1 reference

Intracellular colocalization and interaction of IGF-binding protein-2 with the cyclin-dependent kinase inhibitor p21CIP1/WAF1 during growth inhibition

31 March 2020

1 reference

Patched1 inhibits epidermal progenitor cell expansion and basal cell carcinoma formation by limiting Igfbp2 activity

31 March 2020

1 reference

IGFBP-2 nuclear translocation is mediated by a functional NLS sequence and is essential for its pro-tumorigenic actions in cancer cells

31 March 2020

1 reference

Signal relay by retinoic acid receptors alpha and beta in the retinoic acid-induced expression of insulin-like growth factor-binding protein-3 in breast cancer cells

31 March 2020

1 reference

Thyroid hormone and retinoic acid induce the synthesis of insulin-like growth factor-binding protein-4 in mouse osteoblastic cells

31 March 2020

1 reference

Retinoic acid inhibits cell growth in HPV negative cervical carcinoma cells by induction of insulin-like growth factor binding protein-5 (IGFBP-5) secretion

31 March 2020

1 reference

Rexinoid-induced expression of IGFBP-6 requires RARbeta-dependent permissive cooperation of retinoid receptors and AP-1

31 March 2020

1 reference

Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer

31 March 2020

1 reference

Role of insulin-like growth factor binding protein-3 in 1, 25-dihydroxyvitamin-d 3 -induced breast cancer cell apoptosis

31 March 2020

1 reference

Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts.

31 March 2020

1 reference

A novel interaction between insulin-like growth factor binding protein-6 and the vitamin D receptor inhibits the role of vitamin D3 in osteoblast differentiation

31 March 2020

1 reference

Molecular basis of the interaction between IGFBP-3 and retinoid X receptor: role in modulation of RAR-signaling

31 March 2020

1 reference

Insulin-like growth factor binding protein-6 interacts with the thyroid hormone receptor α1 and modulates the thyroid hormone-response in osteoblastic differentiation

31 March 2020

1 reference

Role of N- and C-terminal residues of insulin-like growth factor (IGF)-binding protein-3 in regulating IGF complex formation and receptor activation

31 March 2020

1 reference

Promotion of cancer cell migration: an insulin-like growth factor (IGF)-independent action of IGF-binding protein-6

31 March 2020

1 reference

Structural and functional insights into nuclear receptor signaling.

31 March 2020

1 reference

Induction of apoptosis in human prostate cancer cells by insulin-like growth factor binding protein-3 does not require binding to retinoid X receptor-alpha

31 March 2020

1 reference

Transforming growth factor-beta stimulates production of insulin-like growth factor-binding protein-3 by human skin fibroblasts

31 March 2020

1 reference

Differential interactions between IGFBP-3 and transforming growth factor-beta (TGF-beta) in normal vs cancerous breast epithelial cells

31 March 2020

1 reference

TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells

31 March 2020

1 reference

Insulin-like growth factor binding protein-2 mediates the inhibition of DNA synthesis by transforming growth factor-beta in mink lung epithelial cells

31 March 2020

1 reference

Transforming growth factor-beta regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts

31 March 2020

1 reference

TGF-beta modulates beta-Catenin stability and signaling in mesenchymal proliferations

31 March 2020

1 reference

Skeletal growth factors regulate the synthesis of insulin-like growth factor binding protein-5 in bone cell cultures

31 March 2020

1 reference

Insulin-like growth factor binding protein (IGFBP)-5 is upregulated during both differentiation and apoptosis in primary cultures of mouse mammary epithelial cells

31 March 2020

1 reference

Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.

31 March 2020

1 reference

IGFBP-3 activates TGF-beta receptors and directly inhibits growth in human intestinal smooth muscle cells

31 March 2020

1 reference

Transforming growth factor-{beta} (TGF{beta}) receptors I/II differentially regulate TGF{beta}1 and IGF-binding protein-3 mitogenic effects in the human placenta

31 March 2020

1 reference

Interaction between IGF binding protein-3 and TGFβ in the regulation of adipocyte differentiation

31 March 2020

1 reference

IGF binding protein 3 exerts its ligand-independent action by antagonizing BMP in zebrafish embryos

31 March 2020

1 reference

Tobacco specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone suppresses a newly identified anti-tumor IGFBP-3/IGFBP-3R system in lung cancer cells

31 March 2020

1 reference

Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I

31 March 2020

1 reference

Phosphorylation of IGFBP-1 at discrete sites elicits variable effects on IGF-I receptor autophosphorylation

31 March 2020

1 reference

Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice

31 March 2020

1 reference

Differential IGF-independent effects of insulin-like growth factor binding proteins (1-6) on apoptosis of breast epithelial cells.

31 March 2020

1 reference

IGFBP-4 tumor and serum levels are increased across all stages of epithelial ovarian cancer

31 March 2020

1 reference

Endoglin regulates cancer-stromal cell interactions in prostate tumors

31 March 2020

1 reference

Prohibitin-2 binding modulates insulin-like growth factor-binding protein-6 (IGFBP-6)-induced rhabdomyosarcoma cell migration

31 March 2020

1 reference

IGFBP-2 overexpression reduces the appearance of dysplastic aberrant crypt foci and inhibits growth of adenomas in chemically induced colorectal carcinogenesis

31 March 2020

1 reference

Insulin-like growth factor binding protein 2 promotes glioma development and progression

31 March 2020

1 reference

Insulin-like growth factor binding protein-2 stimulates proliferation and activates multiple cascades of the mitogen-activated protein kinase pathways in NIH-OVCAR3 human epithelial ovarian cancer cells

31 March 2020

1 reference

Proliferation of DU145 prostate cancer cells is inhibited by suppressing insulin-like growth factor binding protein-2.

31 March 2020

1 reference

Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24.

31 March 2020

1 reference

Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion

31 March 2020

1 reference

IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion

31 March 2020

1 reference

PTEN-induction in U251 glioma cells decreases the expression of insulin-like growth factor binding protein-2.

31 March 2020

1 reference

Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer

31 March 2020

1 reference

Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression

31 March 2020

1 reference

Regulation of protumorigenic pathways by insulin like growth factor binding protein2 and its association along with β-catenin in breast cancer lymph node metastasis

31 March 2020

1 reference

Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo

31 March 2020

1 reference

Silencing of endogenous IGFBP-5 by micro RNA interference affects proliferation, apoptosis and differentiation of neuroblastoma cells.

31 March 2020

1 reference

Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin

31 March 2020

1 reference

Insulin-like growth factor binding protein-5 influences pancreatic cancer cell growth

31 March 2020

1 reference

Tumor-associated retinal astrocytes promote retinoblastoma cell proliferation through production of IGFBP-5

31 March 2020

1 reference

Insulin-like growth factor binding protein 5 enhances survival of LX2 human hepatic stellate cells

31 March 2020

1 reference

Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function.

31 March 2020

1 reference

IGFBP5 induces cell adhesion, increases cell survival and inhibits cell migration in MCF-7 human breast cancer cells.

31 March 2020

1 reference

Signalling pathways involved in the direct effects of IGFBP-5 on breast epithelial cell attachment and survival

31 March 2020

1 reference

Sphingosine 1-phosphate and cancer

31 March 2020

1 reference

Overexpression of IGFBP5, but not IGFBP3, correlates with the histologic grade of human diffuse glioma: a tissue microarray and immunohistochemical study

31 March 2020

1 reference

Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types

31 March 2020

1 reference

Expression level of insulin-like growth factor binding protein 5 mRNA is a prognostic factor for breast cancer

31 March 2020

1 reference

IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder

31 March 2020

1 reference

Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts

31 March 2020

1 reference

Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line

31 March 2020

1 reference

Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I

31 March 2020

1 reference

Megakaryocytes co-localise with hemopoietic stem cells and release cytokines that up-regulate stem cell proliferation.

31 March 2020

1 reference

Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism

31 March 2020

1 reference

Dual effects of IGFBP-3 on endothelial cell apoptosis and survival: involvement of the sphingolipid signaling pathways

31 March 2020

1 reference

Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1

31 March 2020

1 reference

Inhibition of insulin-like growth factor-binding protein-3 signaling through sphingosine kinase-1 sensitizes triple-negative breast cancer cells to EGF receptor blockade.

31 March 2020

1 reference

Insulin-like growth factor binding protein-3 expression is associated with growth stimulation of T47D human breast cancer cells: the role of altered epidermal growth factor signaling.

31 March 2020

1 reference

Differential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer development.

31 March 2020

1 reference

Epidermal growth factor receptor regulates aberrant expression of insulin-like growth factor-binding protein 3

31 March 2020

1 reference

A non-IGF binding mutant of IGFBP-3 modulates cell function in breast epithelial cells

31 March 2020

1 reference

Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase).

31 March 2020

1 reference

Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation

31 March 2020

1 reference

Intrinsic, Pro-Apoptotic Effects of IGFBP-3 on Breast Cancer Cells are Reversible: Involvement of PKA, Rho, and Ceramide

31 March 2020

1 reference

Integrin-associated Lyn kinase promotes cell survival by suppressing acid sphingomyelinase activity

31 March 2020

1 reference

Sphingolipids: regulators of crosstalk between apoptosis and autophagy

31 March 2020

1 reference

Cancer-derived p53 mutants suppress p53-target gene expression--potential mechanism for gain of function of mutant p53.

31 March 2020

1 reference

p53-Dependent and p53-independent induction of insulin-like growth factor binding protein-3 by deoxyribonucleic acid damage and hypoxia.

31 March 2020

1 reference

IGFBP3 and BAG1 enhance radiation-induced apoptosis in squamous esophageal cancer cells

31 March 2020

1 reference

Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3.

31 March 2020

1 reference

Insulin-like growth factor-binding protein-3 suppresses tumor growth via activation of caspase-dependent apoptosis and cross-talk with NF-κB signaling

31 March 2020

1 reference

Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatment

31 March 2020

1 reference

Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK.

31 March 2020

1 reference

Phosphorylation of insulin-like growth factor binding protein-3 by deoxyribonucleic acid-dependent protein kinase reduces ligand binding and enhances nuclear accumulation

31 March 2020

1 reference

Phosphorylation by DNA-dependent protein kinase is critical for apoptosis induction by insulin-like growth factor binding protein-3.

31 March 2020

1 reference

DNA-PK phosphorylation of IGFBP-3 is required to prevent apoptosis in retinal endothelial cells cultured in high glucose

31 March 2020

1 reference

Utility of free IGF-I measurements

31 March 2020

1 reference

Identification of head and neck squamous cell carcinoma biomarker candidates through proteomic analysis of cancer cell secretome.

31 March 2020

1 reference

Association of insulin-like growth factor binding protein-3 expression with melanoma progression

31 March 2020

1 reference

Met proto-oncogene and insulin-like growth factor binding protein 3 overexpression correlates with metastatic ability in well-differentiated pancreatic endocrine neoplasms

31 March 2020

1 reference

Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status

31 March 2020

1 reference

Correlation of Insulin-Like Growth Factor-Binding Protein-3 Messenger RNA With Protein Expression in Primary Breast Cancer Tissues: Detection of Higher Levels in Tumors With Poor Prognostic Features

31 March 2020

1 reference

Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer

31 March 2020

1 reference

IGFBP3 mRNA expression in benign and malignant breast tumors

31 March 2020

1 reference

Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics

31 March 2020

1 reference

IGFBP-3 gene expression and estrogen receptor status in human breast carcinoma

31 March 2020

1 reference

12 December 2020

Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter?

1 reference

12 December 2020

Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor

1 reference

12 December 2020

Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor

1 reference

12 December 2020

Altered expression of members of the IGF-axis in clear cell renal cell carcinoma

1 reference

12 December 2020

Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors.

1 reference

12 December 2020

Molecular distribution of IGF binding protein-5 in human serum.

1 reference

12 December 2020

Introduction of insulin-like growth factor binding protein-2 gene into human bladder cancer cells enhances their metastatic potential.

1 reference

12 December 2020

Placental protein 12 (PP12) in primary liver cancer and cirrhosis

1 reference

12 December 2020

Insulin-like growth factor binding proteins-2 and -4 enhance the migration of human CD34-/CD133+ hematopoietic stem and progenitor cells.

1 reference

12 December 2020

Insulin-like growth factor binding protein 1 expression inhibits insulin-like growth factor I action in MCF-7 breast cancer cells

1 reference

12 December 2020

IGFBP-3 prolongs the p53 response and enhances apoptosis following UV irradiation

1 reference

12 December 2020

Biology of insulin-like growth factor binding protein-4 and its role in cancer (review).

1 reference

12 December 2020

Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells

1 reference

12 December 2020

Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.

1 reference

12 December 2020

Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models

1 reference

12 December 2020

Insulin-like growth factor binding protein-1 (IGFBP-1) inhibits breast cancer cell motility.

1 reference

12 December 2020

Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis

1 reference

12 December 2020

Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen

1 reference

12 December 2020

IGFBP-3 and IGFBP-5 production by human intestinal muscle: reciprocal regulation by endogenous TGF-beta1.

1 reference

12 December 2020

Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins

1 reference

12 December 2020

Acute and Short-Term Effects of Growth Hormone on Insulin-Like Growth Factors and Their Binding Proteins: Serum Levels and Hepatic Messenger Ribonucleic Acid Responses in Humans1

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRC3720

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24722429%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

13 June 2020

1021093070

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017